ASTELLAS PHARMA KOREA, INC.

ACTIVE

7/F, Seoul, 首尔特别市, South Koreawww.astellas.co.krSubsidiary

Part of Astellas Pharma, Inc.

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 4

61.9%

Phase 3

4.8%

Trial Status Distribution

Active, not recruiting

4.8%

Completed

61.9%

Not yet recruiting

9.5%

Recruiting

9.5%

Terminated

14.3%

Clinical Trials

Trials sponsored by this organization (21)

A Study to Track the Safety of Vesomni in Men in South Korea Treated in Routine Clinical Practice for the Urinary Symptoms of Benign Prostatic Hyperplasia (Enlarged Prostate)

Not yet recruiting

observational

Sep 2026600 participants

A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Recruiting

observational

Apr 2025377 participants

Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients

Completed

observational

Jul 202423 participants

A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

Recruiting

observational

Nov 2023202 participants

A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation

Completed

observational

Jun 202233 participants

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

Phase 4

Completed

interventional

Feb 201921 participants

A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria

Phase 4

Terminated

interventional

Apr 201733 participants

Trial on the therapeutic effect of Tacrolimus in combination with low dosage corticosteroids compared with high dosage corticosteroids only, in patients with minimal change necrotic syndrome

Active, not recruiting

Jul 2015152 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations